Announcements Trials

Browse Landscape

Phase

Phase 2 9 Phase NA 5 Phase 1 4 Phase EARLY_PHASE1 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 275 Brain Neoplasms 169 Glioma 139 Central Nervous System Neoplasms 85 Gliosarcoma 79 Astrocytoma 74 Neuroblastoma 64 Oligodendroglioma 42 Neoplasms 40 Breast Neoplasms 38 Recurrence 37 Carcinoma, Non-Small-Cell Lung 30 Medulloblastoma 27 Melanoma 26 Ovarian Neoplasms 24 Lymphoma 21 Diffuse Intrinsic Pontine Glioma 21 Sarcoma 19 Neoplasm Metastasis 19 Lung Neoplasms 18 Colorectal Neoplasms 17 Rhabdomyosarcoma 16 Osteosarcoma 16 Meningeal Carcinomatosis 15 Ependymoma 15 Pancreatic Neoplasms 14 Meningioma 14 Sarcoma, Ewing 13 Stomach Neoplasms 12 Esophageal Neoplasms 12

Interventions

Imatinib Mesylate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Neurofibroma × CNS × Clear all

NCT01140360 2017-07-02

0908-09

Indiana University

Phase 1/2 Completed

21 enrolled 8 charts

Neurofibroma, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon ⚡